ANN ARBOR, Mich.--(BUSINESS WIRE)--Rubicon Genomics, Inc., a developer of pre-analytical amplification products that enable optimal performance of advanced genetic analysis tools, announced today that it has reached agreement with BlueGnome to non-exclusively market its PicoPlex™ technology to In Vitro Fertilization (IVF) researchers under the name SurePlex DNA Amplification System as part of the BlueGnome 24sure microarray-based technology for aneuploidy screening of 24 chromosomes and other detection systems.
